Medical Journal, Health Articles

Health and medical news to help you live a better life

Archive for the 'Lung Cancer' Category

2nd European Lung Cancer Conference

Rapid advances in drug development, genetics and multidisciplinary treatment have brought the field of oncology to a critical moment, says Dr. Rafael Rosell from the Catalan Institute of Oncology in Badalona, Spain, co-chair of the second European Lung Cancer Conference (ELCC), which will be held in Geneva, Switzerland from 28 April to 1 May 2010…Original post by Dental Heroes

Read entire article

No comments

Prolonged Use Of HRT Increases Incidence Of Lung Cancer By About 50 Percent: New Study

Women aged 50 to 76 who take estrogen plus progestin may have an increased risk of lung cancer, according to a new study published in the pre-print online edition of the Journal of Clinical Oncology…Original post by Dental Heroes

Read entire article

No comments

‘Salvage’ Therapy Just As Suitable For NSCLC Patients Over Age 70 As For Younger Patients

Research published in the March issue of the Journal of Thoracic Oncology sought to determine whether differences existed in tolerance and efficacy between patients age 70 and over and younger patients with non-small cell lung cancer (NSCLC) receiving salvage targeted therapy with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) or chemotherapy…Original post by Dental Heroes

Read entire article

No comments

Merrimack Pharmaceuticals Initiates Enrollment In A Phase 1/2 Combination Study Of MM-121 And Tarceva(R) In Patients With Non-Small Cell Lung Cancer

Merrimack Pharmaceuticals, Inc. announced that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva® (erlotinib) in patients with non-small cell lung cancer (NSCLC). This is the first of multiple trials that Merrimack and sanofi-aventis expect to initiate in 2010 as part of a broad Phase 2 clinical development program for MM-121…Original post by Diabetes Mine

Read entire article

No comments

African-Americans’ Attitudes About Lung Cancer May Hinder Prevention

A new survey has found that African-Americans are more likely than whites to hold mistaken and fatalistic beliefs about lung cancer, as well as being more reluctant to consult a doctor about possible symptoms of the disease, according to researchers from Dana-Farber Cancer Institute and their collaborators…Original post by Fade Library

Read entire article

No comments

In The “Year Of The Lung,” Utah Company Freshmedx Announces Breakthrough Lung Cancer Diagnostic

In celebration of World Cancer Day and the Year of the Lung, Freshmedx today announced that it has entered into multiple discussions for the international license of its Bioconductance Scanning Platform (BSP). The BSP is a medical device that can dramatically improve the accuracy of pre-surgical lung cancer diagnosis in a simple and painless 12-minute scan…Original post by Latest entries from www.anxietyinsights.info

Read entire article

No comments

Erlotinib Found To Be Marginally Cost-Effective In Economic Analysis

Weighing both magnitude of survival benefit and expense, researchers found that the drug erlotinib, which was found to improve overall survival by 2 months in patients with advanced non-small cell lung cancer, is marginally cost-effective…Original post by Diabetes Mine

Read entire article

No comments

Significant Hazards Discovered In New Research On Secondhand Smoke

New research by the Oklahoma Tobacco Research Center (OTRC) shows that concentrations of secondhand tobacco smoke inhaled in smoking rooms of restaurants and bars are exceptionally high and hazardous to health…Original post by Diabetes Mine

Read entire article

No comments

Surgery Alone Offers Reasonable Overall Survival For Stage I SCLC

Research published in February’s edition of the Journal of Thoracic Oncology investigates the utilization of surgery and the subsequent need for radiotherapy (RT) when treating stage I small cell lung cancer (SCLC)…Original post by Diabetes Mine

Read entire article

No comments

First Actuarial Analysis Shows Significant Mortality Reduction When Lung Cancer Diagnosed Early

The first ever actuarial analysis of lung cancer mortality, published in Population Health Management Journal, provides strong evidence that earlier detection could reduce the number of late stage lung cancer deaths by over 70,000 people each year in the US…Original post by Diabetes Mine

Read entire article

No comments

Next Page »